Skip to main content
MedPathMedPath Home
Clinical Trials/PACTR202001787868341
PACTR202001787868341
Completed
未知

gonadotropin releasing hormone GnRH-agonist trigger versus human chorionic gonadotropin HCG trigger in cases of controlled ovarian stimulation

faculty of medicine alexandria university0 sites300 target enrollmentJanuary 3, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
faculty of medicine alexandria university
Enrollment
300
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 3, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Age between 20\-40 years.
  • •2\.Regular ovulatory menstrual cycles.
  • •3\. Normal male factor
  • •4\.Normal hystrosalpengiogram

Exclusion Criteria

  • •1\.Previous uterine surgery.
  • •2\.Evidence of endometrial, uterine or pelvic pathology.
  • •3\.Medical disorders or regular intake of medications.
  • •4\.Poor ovarian reserve

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Gonadotropin-releasing hormone (GnRH) agonist for prevention of chemotherapy induced menopause in malignant ovarian germ cell tumor: a multicenter studyDiseases of The genitoruinary system
KCT0003286Bundang CHA General Hospital65
Completed
Not Applicable
Gonadotropin releasing hormone agonist flare-up versus gonatotropin releasing hormone antagonist protocols in poor responders undergoing ICSI:RCT
PACTR201704002212265Airforce specialized hospital106
Unknown
Not Applicable
Antagonist versus agonist protocols: in patients with polycystic ovary syndrome treated for ICSI cyclesFertility-femaleInfertility in PCOS patients
PACTR201411000933365Obestetrics and Gynaecology Department, Faculty of Medicine, University of Alexandria200
Completed
Phase 4
Ganirelix in insemination cycles of women with premature luteinizatioinfertilityintrauterine inseminationReproductive Health and Childbirth - Fertility including in vitro fertilisation
ACTRN12612000153819Mersin University114
Recruiting
Phase 2
Women undergoing chemotherapy plus gonadotrophin-releasing hormone (GnRH) analouges compared with control to protect ovairan functioWomen of reproductive age receiving chemotherapyCancerReproductive Health and Childbirth - Fertility including in vitro fertilisationCancer - Breast
ACTRN12609001059257Ass. Prof. Dr. Eman Elgindy100